Keke Nie | Oncology | Best Researcher Award

Published on by China Scientist

Prof. Dr. Keke Nie | Oncology | Best Researcher Award 

Dr. Keke Nie is a dedicated medical oncologist specializing in thoracic radio-oncology. She currently serves as the Director of Oncology at Qingdao Central Hospital, University of Health and Rehabilitation Sciences. With extensive clinical experience in lung and gastrointestinal cancers, she has led numerous research initiatives focused on improving cancer treatment outcomes. Dr. Nie holds an MD from Weifang Medical University and an MS from Qingdao University Medical School. Her expertise spans clinical trial design, surgical procedures, and medical research, making her a key figure in advancing oncology care in China.

Prof. Dr. Keke Nie | Qingdao Central Hospital | China

Profile

SCOPUS

ORCID

Education

  • Dr. Keke Nie pursued her foundational medical training at Weifang Medical University in China, where she earned her medical degree. She continued her academic journey at Qingdao University Medical School, where she completed a master’s program in clinical medicine. Her formal education laid a strong foundation for her clinical practice and research in the fields of thoracic radio-oncology and medical oncology.

Experience

  • Dr. Nie currently serves as the Director of Oncology at Qingdao Central Hospital, affiliated with the University of Health and Rehabilitation Sciences. In this leadership role, she is actively involved in designing and implementing clinical research studies, particularly in lung cancer and gastrointestinal cancer. Prior to this, she worked for over a decade at Qingdao Cancer Hospital and Institute as an attending physician. There, she was responsible for patient care and clinical investigation, with a focus on lung, colon, breast, and ovarian cancers, especially in the post-surgical context. Her career reflects a continuous dedication to cancer treatment and patient-centered care.

Awards and Recognition

  • Dr. Nie’s appointment as Director of Oncology and her long-standing contributions to leading institutions in Qingdao reflect recognition of her clinical excellence and research capability. Her leadership in designing clinical studies indicates the trust placed in her expertise by the medical and scientific community.

Skills and Expertise

  • Dr. Nie is proficient in various software tools essential for medical research and documentation, including Microsoft Office, Sigmaplot, and Photoshop. She has practical knowledge of clinical trial protocols, including the preparation of new drug studies and the development of novel treatment techniques. In addition, she possesses hands-on surgical experience, particularly in general surgery, which supports her work in oncology care.

Research Focus 

  • Dr. Nie’s primary research interests lie in thoracic radio-oncology and medical oncology. She is especially focused on developing clinical research protocols and conducting studies that enhance treatment outcomes for lung and gastrointestinal cancers. Her experience bridges both clinical practice and laboratory-based research, providing her with a comprehensive understanding of cancer therapeutics.

Publications

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, M Shen
Journal: Autophagy

Protective mechanism of FSH against oxidative damage in mouse ovarian granulosa cells by repressing autophagy
Authors: M Shen, Y Jiang, Z Guan, Y Cao, L Li, H Liu, S Sun
Journal: Autophagy

Involvement of the up-regulated FoxO1 expression in follicular granulosa cell apoptosis induced by oxidative stress
Authors: M Shen, F Lin, J Zhang, Y Tang, WK Chen, H Liu
Journal: Journal of Biological Chemistry

miR-26b Promotes Granulosa Cell Apoptosis by Targeting ATM during Follicular Atresia in Porcine Ovary
Authors: F Lin, R Li, ZX Pan, B Zhou, DB Yu, XG Wang, XS Ma, J Han, M Shen
Journal: PLoS One

Melatonin protects mouse granulosa cells against oxidative damage by inhibiting FOXO1-mediated autophagy: Implication of an antioxidation-independent mechanism
Authors: M Shen, Y Cao, Y Jiang, Y Wei, H Liu
Journal: Redox Biology

Conclusion

  • Dr. Keke Nie is a self-motivated and diligent medical professional with extensive experience in thoracic radio-oncology and medical oncology. Her clinical insight, combined with a strong foundation in research and technical skills, makes her a valuable contributor to cancer treatment advancements. With a career marked by commitment to patient care and scientific rigor, she continues to play a pivotal role in shaping clinical oncology research and practice in China.

Lina Wang | Oncology | Best Researcher Award

Published on by China Scientist

Assoc Prof Dr.Lina Wang | Oncology | Best Researcher Award

Grant Funding:
  •  Dr. Wang has been the recipient of competitive research funding from the National Natural Science Foundation of China, which further underscores her research capabilities and the recognition of her work at the national level.
Assoc Prof Dr. Lina Wang, Affiliated Hospital of Jining Medical University, China

Profile

Scopus

OrcID

🏛️Early Academic Pursuits

  • Lina Wang completed her Bachelor’s degree at Taishan Medical University (2004-2010), followed by a Master’s degree from Peking Union Medical College (2010-2013). She further pursued her Ph.D. in Medicine at Shanghai Jiao Tong University School of Medicine (2013-2017). With an unrelenting drive for excellence, she completed a postdoctoral fellowship at the University of Maryland School of Medicine (2018-2020), where she deepened her understanding of oncological research and built a strong foundation for her future studies.

👨‍🔬 PROFESSIONAL ENDEAVORS

  • Since July 2017, Lina Wang has been serving as an Associate Professor at the Affiliated Hospital of Jining Medical University. Her professional journey has been marked by significant strides in cancer research, particularly focusing on lung cancer, esophageal cancer, and leukemia. She is committed to advancing cancer diagnosis, treatment, and prognosis through rigorous scientific investigation. Her postdoctoral research at the University of Maryland significantly enhanced her expertise in molecular oncology.

🏆 CONTRIBUTIONS AND RESEARCH FOCUS

  • Lina Wang’s research has brought significant advancements in the understanding of cancer pathogenesis, particularly in lung and esophageal cancers. Her work in developing efficient prognostic models based on cuproptosis and disulfidptosis has established her as a leader in the field of cancer biomarkers. She has extensively explored the molecular mechanisms underlying tumor progression and has validated several diagnostic and prognostic biomarkers for lung adenocarcinoma. Notably, her research on the TGF-β1/SH2B3 axis has provided new insights into the regulation of anoikis resistance and epithelial-mesenchymal transition (EMT) in lung cancer cells. Additionally, her earlier studies demonstrated that the deletion of Stk40 impairs definitive erythropoiesis in mouse fetal livers, contributing to the broader understanding of developmental biology.

📊 IMPACT AND INFLUENCE

  • Lina Wang’s groundbreaking research has not only advanced scientific knowledge but also holds potential to transform clinical practices in cancer diagnosis and treatment. By identifying tumor-associated diagnostic and prognostic markers, her work offers tangible benefits to clinical patients, improving the precision of medical interventions. Her research on the molecular mechanisms driving cancer progression contributes to the development of targeted therapies that can effectively treat aggressive cancers such as lung adenocarcinoma.

💰GRANTS AND FUNDING

  • Lina Wang’s research efforts have been recognized by the National Natural Science Foundation of China, which awarded her a grant (grant no. 81800182) for her project from 2019 to 2021. This funding has enabled her to push the boundaries of cancer research, supporting her work on diagnostic and prognostic markers, as well as molecular mechanisms in oncology.

🏅ACADEMIC CITES

  • Lina Wang’s publications on topics such as cuproptosis and cancer prognosis have been widely cited in scientific literature, reflecting the relevance and influence of her work in the academic community. Her research has contributed to the establishment of new prognostic models, and her findings have been cited in numerous oncology-focused journals, further solidifying her reputation as a key contributor in cancer research.

🚀LEGACY AND FUTURE CONTRIBUTIONS

  • As Lina Wang continues her academic journey, her future contributions promise to further enhance the understanding of cancer mechanisms and improve treatment strategies. With a focus on the identification of novel biomarkers and therapeutic targets, her work is expected to have a lasting impact on the fields of oncology and personalized medicine. Her ongoing research efforts are set to leave a lasting legacy in the medical community, inspiring future generations of researchers.

📄Publications

  •  Construction of lncRNA Prognostic Model Related to Disulfidptosis in Lung Adenocarcinoma
    Authors: Zhang, L., Wang, S., Wang, L.
    Journal: Heliyon, 2024, 10(15), e35657
  •  Prognostic Value and Immunological Function of Cuproptosis-Related Genes in Lung Adenocarcinoma
    Authors: Zhang, L., Wang, S., Wang, L.
    Journal: Heliyon, 2024, 10(9), e30446
  • LncRNA CALML3-AS1 Modulated by m6A Modification Induces BTNL9 Methylation to Drive Non-Small-Cell Lung Cancer Progression
    Authors: Zhang, H., Wang, S.-Q., Zhu, J.-B., Duan, C.-J., Zhang, C.-F.
    Journal: Cancer Gene Therapy, 2023, 30(12), pp. 1649–1662
  •  Research Progress on Ferroptosis in Lung Cancer 
    Authors: Dong, Z., Wang, L., Zhang, L., Hu, R.
    Journal: Journal of Chinese Physician, 2023, 25(11), pp. 1754–1757
  •  Alterations of Gut Microbiota and Gut Metabolites in the Young-Adult Vitiligo Patients
    Authors: Wu, Q., Cheng, P., Shao, T., Yao, S., Lu, B.
    Journal: Journal of the European Academy of Dermatology and Venereology, 2023, 37(7), pp. e904–e907